These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4166020)

  • 1. Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and injection of inactivated vaccines.
    Smith CB; Bellanti JA; Chanock RM
    J Immunol; 1967 Jul; 99(1):133-41. PubMed ID: 4166020
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective effect of antibody to parainfluenza type 1 virus.
    Smith CB; Purcell RH; Bellanti JA; Chanock RM
    N Engl J Med; 1966 Nov; 275(21):1145-52. PubMed ID: 4288591
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunohistological study of a case of exanthema associated with infection caused by parainfluenza virus, type 3].
    Aiuti F; Rocchi G
    G Mal Infett Parassit; 1970 Jun; 22(6):364-6. PubMed ID: 4195898
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity against parainfluenza-3 virus in cattle; immunoglobulins in serum and nasal secretions after subcutaneous and nasal vaccination.
    Morein B
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jul; 144(1):63-74. PubMed ID: 4377636
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental challenge of beef calves vaccinated intranasally with bovine myxovirus parainfluenza-3 vaccine.
    Woods GT; Mansfield ME; Krone J
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):763-6. PubMed ID: 4356215
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity of inactivated parainfluenza type 1, type 2, and type 3 vaccines in infants.
    Kim HW; Canchola JG; Vargosko AJ; Arrobio JO; De Meio JL; Parrott RH
    JAMA; 1966 Jun; 196(10):819-24. PubMed ID: 4287082
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody response of calves after intranasal inoculation with parainfluenza-3 virus and resistance of inoculated calves to experimental homologous viral infection.
    Marshall RG
    Am J Vet Res; 1981 Jun; 42(6):907-11. PubMed ID: 6269470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities of immunoprophylaxis of viral infections].
    Schierz G
    Munch Med Wochenschr; 1968 Mar; 110(12):693-6. PubMed ID: 4175272
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the level of antibodies against parainfluenza type 3 virus].
    Wilczyński J; Luczak M
    Przegl Epidemiol; 1967; 21(3):347-51. PubMed ID: 4294179
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics of the immunological reaction in children with parainfluenza].
    Nisevich LL; Ivanova LA; Balnokina SI; Iakhno MA
    Vopr Okhr Materin Det; 1968 Oct; 13(10):12-7. PubMed ID: 4305474
    [No Abstract]   [Full Text] [Related]  

  • 11. The response of ponies to Myxovirus influenzae A-equi 2. II. Immunoglobulin classes of antibody to the virus in serum and nasal secretions.
    Rouse BT; Ditchfield WJ
    Can J Comp Med; 1970 Jan; 34(1):7-12. PubMed ID: 4192439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing activity in nasal secretions and serum in resistance of volunteers to parainfluenza virus type 2.
    Tremonti LP; Lin JS; Jackson GG
    J Immunol; 1968 Sep; 101(3):572-7. PubMed ID: 4300152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the influence of thymus extracts on the immunological response in experimental influenza. II. Studies of the action of some thymus extracts in influenza immunization].
    Babeş VT; Stoian N; Bădescu D; Boeru V; Dinu E
    Stud Cercet Inframicrobiol; 1970; 21(3):179-94. PubMed ID: 4195469
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunresponse of Syrian hamsters, mice and rabbits after intranasal or subcutaneous application of different parainfluenza-3-vaccine-viruses (author's transl)].
    Moos M
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1980; 74():22-9. PubMed ID: 6257165
    [No Abstract]   [Full Text] [Related]  

  • 15. Viral infections and local IgA.
    N Engl J Med; 1969 Mar; 280(12):666-7. PubMed ID: 4179402
    [No Abstract]   [Full Text] [Related]  

  • 16. Partial protection of calves against parainfluenza-3 virus infection by nasal-secretion interferon induced by infectious bovine rhinotracheitis virus.
    Cummins JM; Rosenquist BD
    Am J Vet Res; 1982 Aug; 43(8):1334-8. PubMed ID: 6179445
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of inactivated vaccines prepared with parainfluenza viruses type 1 and type 3, administered experimentally by nasal or oral route.
    Petrescu AL; Petica M; Bârnaure F; Athanasiu P
    Rom J Virol; 1998; 49(1-4):97-115. PubMed ID: 10892431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the neutralizing activity in nasal wash and serum following intranasal vaccinaion with inactivated type 13 rhinovirus.
    Knopf HL; Perkins JC; Bertran DM; Kapikian AZ; Chanock RM
    J Immunol; 1970 Mar; 104(3):566-73. PubMed ID: 4314177
    [No Abstract]   [Full Text] [Related]  

  • 20. Specificity of respiratory secretion antibody against influenza virus.
    Waldman RH; Wigley FM Small PA
    J Immunol; 1970 Dec; 105(6):1477-83. PubMed ID: 4320734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.